Accenture develops innovative strategy to help streamline consumer experience -
A new study reveals that for adolescent girls, having a romantic relationship play out differently than they imagined it would has negative implications for their mental health.
Enrollment extensions wind down but health law politics getting complicated -
Iconic Therapeutics, Inc., a biotechnology company focused on developing therapeutics for serious eye disorders, announced today that it has successfully completed a $20 million Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures.
Depressive traits linked to greater suicide risk in bipolar disorder -
People with a history of schizophrenia appear to have a lower risk of developing rheumatoid arthritis than the general population, but the association may be due to underreporting, say researchers.
Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease -
Hooper Holmes and Clinical Reference Laboratory, Inc. today announced that they have entered into a Strategic Alliance Agreement under which CRL will become Hooper Holmes' exclusive provider of laboratory testing services and Hooper Holmes will become a member of CRL's preferred provider network for wellness programs.
Humana's members now get access to Dignity Health facilities in Arizona -
Parabon Computation announced today the launch of the Compute Against Alzheimer's Disease (CAAD) research initiative, which will accelerate investigations into the causes and risks of Alzheimer's Disease (AD) through the application of large-scale computational capacity donated by concerned citizens and organizations.